Skip to main content

Part of UT Health San Antonio

Graduate School of Biomedical Sciences, UT Health San AntonioGraduate School of Biomedical Sciences, UT Health San Antonio

Part of UT Health San Antonio

Give
Search

Quicklinks

Commencement

  • Commencement 2021

Logins

  • Canvas
  • CourseLeaf
  • IMPACT
  • LiveMail
  • Syllabus Depot
  • My UT Health (Intranet)

Resources

  • COVID-19 Updates for Students
  • Enrolled Student Resources
  • Educational Resources
  • GSBS Data Request Form

 Close Quicklinks

 
Menu
  • About
  • Admissions
  • Programs
  • Research
  • Faculty
  • Student Life
  • Alumni

You are here

  • Student Directory
  • Brian Iskra
Brian Iskra

Programs

  • Ph.D. in Integrated Biomedical Sciences
  • South Texas Medical Scientist Training Program (MD/PhD Program)

IBMS Discipline

  • Cancer Biology

Mentor

  • Greg Aune, M.D., Ph.D.

Brian Iskra, Ph.D.

M.D./Ph.D.Student

Biography

Brian Iskra completed his Ph.D. in the lab of Greg Aune, MD, PhD in the spring of 2020. As a student in the South Texas Medical Scientist Training Program (MD/PhD Program), Brian has transitioned back to medical school for his final two years of clinical training before an anticipated MD graduation of May 2023.

His graduate project focused on developing novel approaches to understand how anthracycline agents induce cardiac disease in childhood cancer survivors. In particular, he developed protocols for obtaining single cell suspensions for single cell analysis, preparing cells for single cell RNA sequencing, and performing mass cytometry on cardiac non-myocytes. Additionally, he developed a joint analysis methods to identify cell populations in mass cytometry and single cell RNA sequencing datasets, expediting data analysis as well as enabling high confidence assessment of cell identity in mass cytometry data. His expertise in single cell analysis methods covers data preprocessing/primary analysis, traditional approaches to single cell analysis, and deep learning as well as unsupervised and supervised learning. In addition to working on cardiac disease, Brian has collaborated on projects involving Ewing-Sarcoma, where he has employed his understanding of single cell data analysis and biology.

Other projects Brian has been involved with include murine echocardiography, where he developed expertise in systology, diastology, and strain imaging. In addition, he has expertise in confocal microscopy, confocal sample preparation, and high-throughput image analysis. Further, he established various transgenic mouse lines that utilized tamoxifen-inducible Cre-lox systems. 

 

  • About Me
  • Publications
  • Education
  • Awards

About me

Brian Iskra completed his Ph.D. in the lab of Greg Aune, MD, PhD in the spring of 2020. As a student in the South Texas Medical Scientist Training Program (MD/PhD Program), Brian has transitioned back to medical school for his final two years of clinical training before an anticipated MD graduation of May 2023.

Hobbies/Interests

Video games, woodworking

Research Topic

Doxorubicin-induced cardiomyopathy in non-myocytes of the heart

Why I chose MD/PhD

I liked medicine and science. I don't think I would be fulfilled doing only one or the other.

Why I chose MD/PhD at UT Health San Antonio

UTHSA has a strong cancer biology and biology of aging program as well as medical school.

Publications

Miller HE, Gorthi A, Bassani N, Lawrence LA, Iskra BS, Bishop AJR. Reconstruction of Ewing Sarcoma Developmental Context from Mass-Scale Transcriptomics Reveals Characteristics of EWSR1-FLI1 Permissibility. Cancers. 2020; 12(4):948.

Mancilla TR, Iskra B, Aune GJ. Doxorubicin-Induced Cardiomyopathy in Children. Compr Physiol. 2019 Jun 12;9(3):905-931. doi: 10.1002/cphy.c180017. PMID: 31187890

Wang F, Iskra B, Kleinerman E, Alvarez-Florez C, Andrews T, Shaw A, Chandra J, Schadler K, Aune GJ. Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity. J Pediatr Hematol Oncol. 2018 Apr;40(3):208-215. doi: 10.1097/MPH.0000000000001112. PMID: 29557918

Kim SK, Barron L, Hinck CS, Petrunak EM, Cano KE, Thangirala A, Iskra B, Brothers M, Vonberg M, Leal B, Richter B, Kodali R, Taylor AB, Du S, Barnes CO, Sulea T, Calero G, Hart PJ, Hart MJ, Demeler B, Hinck AP. An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling. J Biol Chem. 2017 Apr 28;292(17):7173-7188. doi: 10.1074/jbc.M116.768754. Epub 2017 Feb 22. PMID: 28228478

Education

B.S., Mathematics, City University of New York, 2012

Ph.D., Integrated Biomedical Sciences: Cancer Biology, UT Health San Antonio, 2020

Dissertation Title: "Assessing the Heterogeneity of Cardiac Non-Myocytes and the Effect of Cell Culture with Integrative Single Cell Analysis." Defended on April 8, 2020.

Awards

2017-2022 NIA F30: F30AG057213 "Targeting Doxorubicin-Induced Mitochondrial Failure in Mesenchymal Stem Cells with Metformin"

Map image of UT Health San Antonio location
UT Health San Antonio
Graduate School of Biomedical Sciences

7703 Floyd Curl Drive

San Antonio, TX 78229

210-567-3709

gsbs@uthscsa.edu

  • About us
  • Contact us
  • Maps & directions

We make lives better ®

The University of Texas Health Science Center at San Antonio, also called UT Health San Antonio, is a leading academic health center with a mission to make lives better through excellence in advanced academics, life-saving research and comprehensive clinical care including health, dental and cancer services.

Web Privacy | Links from websites affiliated with UT Health's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.